ABC | Volume 113, Nº4, October 2019

Updated Updated Cardiovascular Prevention Guideline of the Brazilian Society Of Cardiology – 2019 Arq Bras Cardiol. 2019; 113(4):787-891 Universidade do Sul de SC (Unisul), 49 Florianópolis, SC – Brazil Instituto Nacional de Cardiologia do Rio de Janeiro, 50 Rio de Janeiro, RJ – Brazil Laboratório de Lípides (LIM10), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, 51 São Paulo, SP – Brazil Instituto de Nutrição Roberta Lara, 52 Itu, SP – Brazil Diadia Nutrição e Gastronomia, 53 Itu, SP – Brazil CLINIMEX, 54 Rio de Janeiro, RJ – Brazil Fitcordis Medicina do Exercício, 55 Brasília, DF – Brazil Universidade Federal do Paraná (UFPR), 56 Curitiba, PR – Brazil Santa Casa de Misericórdia de Porto Alegre, 57 Porto Alegre, RS – Brazil Hospital Santa Joana Recife, 58 Recife, PE – Brazil Hospital Agamenon Magalhães,59 Recife, PE – Brazil Universidade Federal da Bahia (UFBA), 60 Salvador, BA – Brazil Cardio Clínica do Vale, 61 Lajeado, RS – Brazil Hospital São Francisco, 62 Porto Alegre, RS – Brazil These updatedt should be cited as: Précoma DB, Oliveira GMM, Simão AF, Dutra OP, Coelho OR, Izar MCO, et al. Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology – 2019. Arq Bras Cardiol. 2019; 113(4):787-891 Note: The purpose of these Guidelines is to inform. They do not substitute the clinical judgment of doctors who, in final analysis, must determine which tests and treatments are appropriate for their patients. Corresponding Address: Sociedade Brasileira de Cardiologia – Av. Marechal Câmara, 360/330 – Centro – Rio de Janeiro – Postal Code: 20020-907. E-mail: sbc@cardiol.br ; diretrizes@cardiol.br In this update, grade of recommendations and level of evidence were applied in accordance with the following standards: Grade of recommendation Grade I Conditions for which there is conclusive evidence or, in the absence of conclusive evidence, general consensus that the procedure is safe and useful/ effective Grade IIa Conditions for which there are conflicting evidence and/or divergent opinions regarding the procedure’s safety and usefulness/effectiveness. Weight or evidence/opinion in favor of the procedure. The majority of studies/experts approve. Grade IIb Conditions for which there are conflicting evidence and/or divergent opinions regarding the procedure’s safety and usefulness/effectiveness. Safety and usefulness/effectiveness less well established, with no prevailing opinions in favor. Grade III Conditions for which there is evidence and/or consensus that the procedure is not useful/effective and may, in some cases, be potentially harmful Level of evidence Level A Data obtained from multiple concordant large randomized trials and/or robust meta-analysis of randomized clinical trials Level B Data obtained from less robust meta-analysis, from a single randomized trial, or from non-randomized (observational) trials Level C Data obtained through consensus of expert opinion 790